UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia

British journal of haematology, 2023-01, Vol.200 (1), p.e13-e16

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing

British journal of haematology, 2024-03, Vol.204 (3), p.910-920

2024

Link zum Volltext

Verfügbarkeit prüfen

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

Blood, 2022-12, Vol.140 (22), p.2407-2411

2022

Link zum Volltext

Verfügbarkeit prüfen

Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all‐trans retinoic acid and arsenic trioxide sensitivity

British journal of haematology, 2023-08, Vol.202 (4), p.893-896

2023

Link zum Volltext

Verfügbarkeit prüfen

Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia

Antimicrobial agents and chemotherapy, 2017-11, Vol.61 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms

American journal of hematology, 2022-08, Vol.97 (8), p.1013-1022

2022

Link zum Volltext

Verfügbarkeit prüfen

Apparent ‘JAK2‐negative’ polycythaemia vera due to compound mutations in exon 14

British journal of haematology, 2017-07, Vol.178 (2), p.333-336

2017

Link zum Volltext

Verfügbarkeit prüfen

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia

EJHaem, 2023-11, Vol.4 (4), p.1105-1109

2023

Link zum Volltext

Verfügbarkeit prüfen

Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities

Journal of medical microbiology, 2011-03, Vol.60 (3), p.366-370

2011

Link zum Volltext

Verfügbarkeit prüfen

Visual acuity as measured with Landolt C chart and Early Treatment of Diabetic Retinopathy Study (ETDRS) chart

Graefe's archive for clinical and experimental ophthalmology, 2011-04, Vol.249 (4), p.601-605

2011

Link zum Volltext

Verfügbarkeit prüfen

Primary endometrial uterine Burkitt lymphoma in a 65-year-old woman

Gynecologic oncology reports, 2015-08, Vol.13 (C), p.30-32

2015

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1277-1284

2019

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy

Journal of clinical oncology, 2020-10, Vol.38 (30), p.3506-3517

2020

Link zum Volltext

Verfügbarkeit prüfen

Observations from a national sample exchange program for molecular haematology testing

Pathology, 2024-06, Vol.56 (4), p.540-547

2024

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous Plasmablastic Lymphoma in an Immunocompetent Patient with Long-Term Pyrimethamine Use for Essential Thrombocythemia: A Case Report and Literature Review

Case reports in hematology, 2013-01, Vol.2013, p.541783-6

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications

British journal of haematology, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Low-intensity venetoclax-based salvage as a bridge to allogeneic stem cell transplant in patients with acute myeloid leukemia failing conventional intensive chemotherapy

Leukemia research, 2024-01, Vol.136, p.107429-107429, Article 107429

2024

Link zum Volltext

Verfügbarkeit prüfen

Cellular distribution of IDH mutations in AML during morphologic remission

Leukemia research, 2023-01, Vol.124, p.106993-106993, Article 106993

2023

Link zum Volltext

Verfügbarkeit prüfen

Mutational and Copy Number Profiling of Circulating Tumor DNA in Acute Myeloid Leukemia Using Targeted Next Generation Sequencing

Blood, 2020-11, Vol.136 (Supplement 1), p.39-40

2020

Link zum Volltext

Verfügbarkeit prüfen

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

Journal of antimicrobial chemotherapy, 2015-08, Vol.70 (8), p.2369-2375

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)
Berichte
(2)

Sprache

Englisch
(55)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(20)
Hematology
(18)
Aged
(9)
Oncology
(9)
Female
(7)
Male
(7)
Mutation
(7)
Leukemia
(6)
Leukemia, Myeloid, Acute - Drug Therapy
(6)
Leukemia, Myeloid, Acute - Genetics
(6)
Middle Aged
(6)
Acute Myeloid Leukemia
(5)
Aged, 80 And Over
(5)
Bone Marrow
(5)
Patients
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Hematopoietic Stem Cell Transplantation
(4)
Microbiology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Evaluation of T-cell clonality by anti-TRBC1 antibody-based flow cytometry and correlation with T-cell receptor sequencing

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

Variant acute promyelocytic leukaemia with novel NAB2::RARA fusion shows clinical all‐trans retinoic acid and arsenic trioxide sensitivity

S102: LUSPATERCEPT VERSUS EPOETIN ALFA FOR TREATMENT (TX) OF ANEMIA IN ESA-NAIVE LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS (PTS) REQUIRING RBC TRANSFUSIONS: DATA FROM THE PHASE 3 COMMANDS STUDY

Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia

Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms

Apparent ‘JAK2‐negative’ polycythaemia vera due to compound mutations in exon 14

Persistence of UBTF tandem duplications in remission in acute myeloid leukaemia

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities

Visual acuity as measured with Landolt C chart and Early Treatment of Diabetic Retinopathy Study (ETDRS) chart

Primary endometrial uterine Burkitt lymphoma in a 65-year-old woman

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy

Observations from a national sample exchange program for molecular haematology testing

Cutaneous Plasmablastic Lymphoma in an Immunocompetent Patient with Long-Term Pyrimethamine Use for Essential Thrombocythemia: A Case Report and Literature Review

Immunophenotypic characterisation of acute myeloid leukaemia with UBTF tandem duplications

Low-intensity venetoclax-based salvage as a bridge to allogeneic stem cell transplant in patients with acute myeloid leukemia failing conventional intensive chemotherapy

Cellular distribution of IDH mutations in AML during morphologic remission

Mutational and Copy Number Profiling of Circulating Tumor DNA in Acute Myeloid Leukemia Using Targeted Next Generation Sequencing

Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

Suchergebnisse filtern